TL;DR
Researchers have discovered two novel natural products, ligiamycins A and B, from a co-culture of bacteria isolated from the gut of a marine wharf roach. These compounds feature a rare amino-maleimide structure fused to a decalin core, and ligiamycin A shows promising antibacterial activity.
What Problem Does This Paper Address?
The discovery of new bioactive natural products is crucial for drug development, but the chemical space accessible through traditional single-organism cultivation is often limited. Many microorganisms produce secondary metabolites only when interacting with other species in their natural environment. This paper addresses the challenge of unlocking the biosynthetic potential of microbes by employing a co-culture strategy, specifically focusing on bacteria isolated from the gut of the marine wharf roach, Ligia exotica. The goal was to identify novel compounds that are not produced or are produced in very low quantities by individual strains.
Methods
The researchers employed a multi-faceted approach combining microbiology, advanced spectroscopic techniques, and computational chemistry:
- Microbial Isolation and Co-culture: Bacteria (Streptomyces sp. GET02.ST and Achromobacter sp. GET02.AC) were isolated from the gut of Ligia exotica. They were then cultivated together in a co-culture system, which significantly enhanced the production of target metabolites compared to single cultures.
- Spectroscopic Analysis: A suite of spectroscopic techniques was used for structure elucidation:
- LC/MS (Liquid Chromatography-Mass Spectrometry): Used for initial detection and quantification of compounds, and to monitor the effect of co-culturing.
- HR-ESI-MS (High-Resolution Electrospray Ionization Mass Spectrometry) and HR-FAB-MS (High-Resolution Fast Atom Bombardment Mass Spectrometry): Determined the exact molecular formulas of the new compounds.
- NMR (Nuclear Magnetic Resonance) Spectroscopy: 1D (¹H, ¹³C) and 2D (COSY, HSQC, HMBC) NMR experiments were extensively used to determine the connectivity of atoms and the planar structures of the ligiamycins.
- ¹H-¹⁵N HSQC NMR: Specifically used to assign the positions of nitrogen atoms within the amino-maleimide moiety.
- ROESY (Rotating Frame Overhauser Effect Spectroscopy) NMR: Employed to determine the relative stereochemistry of the decalin core.
- Computational Chemistry:
- ECD (Electronic Circular Dichroism) Calculations: Initially attempted to determine absolute configurations, but experimental data did not align.
- Optical Rotation Calculations: Used to deduce the absolute configurations of the ligiamycins by comparing calculated values with experimentally measured optical rotations.
Datasets
Not discussed in the paper. The study focuses on the isolation and characterization of novel compounds from microbial cultures.
Key Insights and Ideas
- Co-culture as a powerful tool: The study strongly demonstrates that co-culturing symbiotic or ecologically relevant microbes can dramatically enhance the production of previously undiscovered or low-yield natural products. The production of ligiamycin A was increased by approximately 24 times in the co-culture.
- Rarity of the amino-maleimide moiety: The amino-maleimide substructure is exceptionally rare in nature, with only a few examples reported from plants. Ligiamycins A and B represent the first instance of this moiety being found in microbial natural products.
- First bacterial decalin-maleimide metabolites: While decalin and maleimide structures have been found in fungal metabolites, ligiamycins A and B are the first reported bacterial compounds to combine these two features.
- Ecological relevance of gut microbes: The study highlights the potential of exploring the gut microbiota of marine invertebrates, like wharf roaches, as a rich source of novel bioactive compounds.
- Structural novelty: The unique combination of a decalin core with an amino-maleimide ring system presents a novel structural class of natural products.
Key Results
- Discovery of Ligiamycins A and B: Two new metabolites, ligiamycin A (1) and ligiamycin B (2), were isolated and structurally elucidated.
- Structural Features: Both compounds are characterized by a decalin core fused to an amino-maleimide moiety. Ligiamycin B is a hydroxylated analog of ligiamycin A.
- Antibacterial Activity: Ligiamycin A (1) exhibited moderate inhibitory effects against Staphylococcus aureus and Salmonella enterica (MIC of 16 µg/mL for both).
- Cytotoxicity: Ligiamycin B (2) displayed mild cell cytotoxicity against human colorectal cancer cells (HCT116) with an IC50 of 20.1 µM. Ligiamycin A (1) showed no significant cytotoxicity.
- Stereochemistry: The relative configurations of the decalin core were determined as 5R, 6R, 9R, 11S, and 14R* for both compounds. The absolute configurations were also deduced as 5R, 6R, 9R, 11S, and 14R.
Limitations and Future Work
- Mechanism of Co-culture Induction: The exact mechanism by which Achromobacter sp. GET02.AC elicits the production of ligiamycins from Streptomyces sp. GET02.ST remains unclear. The authors suggest potential mechanisms like cell-cell contact or small molecule inducers, but further investigation is needed.
- Biosynthetic Pathway: While a putative biosynthetic pathway involving a polyketide synthase-nonribosomal peptide synthetase (PKS-NRPSs) hybrid pathway is proposed, experimental validation is required.
- Biological Activity Scope: While antibacterial and mild cytotoxic activities were observed, further screening against a broader range of targets (e.g., other bacteria, fungi, viruses, parasites, and various cancer cell lines) could reveal more potent applications.
- Ecological Role: Understanding the ecological role of these compounds in the gut environment of Ligia exotica would be valuable.
Summary updated